Predictors of Failure of Empiric Outpatient Antibiotic Therapy in Emergency Department Patients With Uncomplicated Cellulitis.
NCT01972646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2013-10-30
Summary
Introduction: Despite several expert panel recommendations and cellulitis treatment guidelines, there are currently no clinical decision rules to assist clinicians in deciding which emergency department (ED) patients should be treated with oral antibiotics and which patients require intravenous therapy at first presentation of uncomplicated cellulitis. The objective of this prospective study is to determine potential patient risk factors associated with adult patients (\>17years) presenting to the ED with a concern about a skin or soft tissue infection who fail initial antibiotic therapy for the treatment of standard cellulitis and require a change of antibiotics or admission to hospital.
Methods: This study will be a prospective study conducted in two tertiary care EDs. Patients will be excluded if they have been treated with antibiotics for the current bout of cellulitis prior to presenting to the ED, patients admitted to hospital and those patients with abscesses only. Hired research assistants (RAs) will administer a questionnaire at the initial ED visit with telephone follow-up 2 weeks later. Treatment failure will be defined as patients requiring subsequent hospitalization, initiation of intravenous antibiotics (if oral antibiotics were prescribed initially), or a change of oral antibiotics for the original cellulitis.
Results: This study will provide a detailed profile of patient risk factors associated with treatment failure of cellulitis. The results will be analyzed and used in formulating a clinical decision rule for effective treatment of cellulitis presenting to the ED. Each of the predictor variables associated (p ≤ 0.1) with failed treatment in the univariate analysis will be considered in a multivariate logistic regression model. Additionally, treatment variability among clinicians in regard to cellulitis will be evaluated and compared to treatment failures, thus providing data on successful treatment regimens.
Conclusions: Results from this research may be used to generate a clinical prediction rule to assist clinicians in effectively treating patients presenting to emergency departments with cellulitis. Understanding which patient risk factors for treatment failure will assist clinicians in determining which patients will benefit from intravenous versus oral antibiotics.
Conditions
- Uncomplicated Outpatient Cellulitis
Sponsors & Collaborators
-
University of Western Ontario, Canada
collaborator OTHER -
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Andrew McRae, MD, FRCPC, PhD · The University of Western Ontario
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Cellulitis Optimal Antibiotic Treatment
NCT05584007 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
NCT01029782 ·Status: COMPLETED ·Phase: PHASE2
-
RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg
NCT00552799 ·Status: COMPLETED ·Phase: PHASE4
-
Sonographic Features of Cellulitis and Failure of Therapy
NCT01773499 ·Status: TERMINATED
-
The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
NCT05023200 ·Status: COMPLETED
-
Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting
NCT03036358 ·Status: COMPLETED ·Phase: NA
-
Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
NCT02334124 ·Status: COMPLETED ·Phase: NA
-
Patients Response to Early Switch To Oral:Osteomyelitis Study
NCT02099240 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
NCT03034694 ·Status: COMPLETED ·Phase: NA
-
The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin
NCT01626560 ·Status: COMPLETED ·Phase: PHASE4
-
Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
NCT00676130 ·Status: COMPLETED ·Phase: NA
-
Placement of Antibiotic Powder in Wounds During the Emergency Room
NCT03765567 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
NCT01549613 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses
NCT00973765 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI
NCT04409769 ·Status: COMPLETED
-
Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage
NCT02024867 ·Status: COMPLETED ·Phase: NA
-
Partial Oral Antimicrobials to Treat Infective Endocarditis in People Who Inject Drugs
NCT04544306 ·Status: RECRUITING ·Phase: NA
-
Adjunctive Clindamycin for Cellulitis: C4C Trial.
NCT01876628 ·Status: COMPLETED ·Phase: PHASE4
-
Pathogenicity Factors of Staphylococcus Pettenkoferi in Foot Wounds and Osteitis in Diabetic Patients
NCT06688084 ·Status: ACTIVE_NOT_RECRUITING
-
Partial Oral Antibiotic Treatment for Bacterial Brain Abscess
NCT04140903 ·Status: RECRUITING ·Phase: PHASE4
-
Intravenous Versus Oral Treatment of the Main Acute Infections
NCT06715306 ·Status: RECRUITING ·Phase: NA
-
Rapid Detection of Bacterial Resistance by MALDI-TOF MS and Antibiotic Savings
NCT02860247 ·Status: COMPLETED
-
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT07013864 ·Status: COMPLETED
-
Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
NCT02411331 ·Status: UNKNOWN ·Phase: NA
-
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
NCT01724671 ·Status: UNKNOWN